In sarcoidosis trials, time also matters
Eur Respir J
.
2024 Jan 18;63(1):2301629.
doi: 10.1183/13993003.01629-2023.
Print 2024 Jan.
Authors
Florence Jeny
1
2
,
Hilario Nunes
3
2
,
Dominique Valeyre
2
4
Affiliations
1
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France florence.jeny@aphp.fr.
2
INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, France.
3
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France.
4
Groupe hospitalier Paris Saint Joseph, Pulmonology Department, Paris, France.
PMID:
38237993
DOI:
10.1183/13993003.01629-2023
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Prednisolone
Sarcoidosis* / drug therapy
Sarcoidosis, Pulmonary* / therapy
Substances
Prednisolone